Back
Karyopharm Therapeutics Stock Predictions
Sponsored
KPTI
Sponsored
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
28
KPTI
Karyopharm Therapeutics
Last Price:
0.85
Seasonality Move:
-2.8%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.Karyopharm Therapeutics Stock Forecast
-
Is Karyopharm Therapeutics Stock Undervalued?
The current Karyopharm Therapeutics [KPTI] share price is $0.78. The Score for KPTI is 28, which is 44% below its historic median score of 50, and infers higher risk than normal. - KPTI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Karyopharm Therapeutics Stock Go Up Next Year?
Data Unavailable
Karyopharm Therapeutics Stock Rating
Data Unavailable
Karyopharm Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
karyopharm.com
52-Week Data
52-Week High:
1.95
52-Week Low:
0.62
Prediction Charts
Market Cap:
97.44M
Price in USD:
0.78
Volume:
278.5K
Beta:
0.84
Technical Analysis
SMA50:
0.82
SMA100:
0.84
SMA200:
1.02
52-Wk Change:
5.34%
Stock Predictions
-
Is Karyopharm Therapeutics stock public?
Yes, Karyopharm Therapeutics is a publicly traded company. -
What is the Karyopharm Therapeutics stock quote today?
The Karyopharm Therapeutics stock price is 0.78 USD today. -
How to buy Karyopharm Therapeutics stock online?
You can buy Karyopharm Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Nov-4 | 0.92 | 0.93 | 0.95 | 0.91 |
Nov-5 | 0.91 | 0.85 | 0.93 | 0.85 |
Nov-6 | 0.85 | 0.89 | 0.93 | 0.85 |
Nov-7 | 0.89 | 0.88 | 0.94 | 0.87 |
Nov-8 | 0.88 | 0.88 | 0.92 | 0.86 |
Nov-11 | 0.88 | 0.93 | 0.93 | 0.88 |
Nov-12 | 0.92 | 0.90 | 0.95 | 0.88 |
Nov-13 | 0.90 | 0.87 | 0.92 | 0.85 |
Nov-14 | 0.89 | 0.84 | 0.89 | 0.83 |
Nov-15 | 0.84 | 0.81 | 0.89 | 0.80 |
Nov-18 | 0.83 | 0.79 | 0.86 | 0.78 |
Nov-19 | 0.78 | 0.77 | 0.79 | 0.75 |
Nov-20 | 0.77 | 0.78 | 0.79 | 0.76 |
Nov-21 | 0.76 | 0.78 | 0.80 | 0.76 |
Karyopharm Therapeutics Earnings
Data Unavailable
Karyopharm Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and a decrease next year of $0.01 per share.
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.